Role of the pharmacist in managing polypharmacy among elderly patients in long-term care facilities

Read full text Summarise with VIRAT
Authors: Haruki Tanaka, Yuki Watanabe
Cited by: 0
References: 12

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Polypharmacy commonly defined as the concurrent use of five or more medications affects a majority of elderly residents in long-term care facilities and is associated with higher rates of adverse drug reactions, falls, cognitive decline, and hospitalisation. This research evaluated the impact of a pharmacist-led medication review and deprescribing program on the number of medications, potentially inappropriate medications (PIMs), and clinical outcomes among elderly residents of three long-term care facilities in Ishikawa Prefecture, Japan. A quasi-experimental pre-post design was employed over a 10-month period from April 2023 to January 2024. A total of 186 residents aged 65 years or older and receiving five or more regular medications were enrolled. A clinical pharmacist conducted comprehensive medication reviews using the Screening Tool of Older Persons' Prescriptions (STOPP) and Screening Tool to Alert to Right Treatment (START) criteria, followed by deprescribing recommendations communicated to the attending physician. The mean number of medications per resident decreased from 9.4 (SD 2.8) at baseline to 6.7 (SD 2.1) at 10 months (p

Fields of Study & Subjects

Pharmaceutical Practices and Patient Outcomes Pharmacy and Medical Practices Geriatric Care and Nursing Homes

Publication details

Journal / source
Journal of Pharmacist and Hospital Pharmacy
Volume
3
Issue
1
Pages
25–29
Publication date
1 January 2026
Language
EN